PrecISE (Precision Interventions for Severe Asthma) is a three-year clinical trial
that aims to identify more effective treatments for severe asthma, which affects nearly 10% of people living with asthma worldwide. The study will use an
adaptive designed clinical trial
that will support a personalized medicine approach to identifying
therapies which are tailored to an individual’s disease and treatment
history. PrecISE is sponsored by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH).
For more information about PrecISE, call us at (619) 431-0995 or email us at email@example.com.